These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31769058)

  • 1. Acute myeloid leukemia with a novel CPSF6-RARG variant is sensitive to homoharringtonine and cytarabine chemotherapy.
    Zhang Z; Jiang M; Borthakur G; Luan S; Huang X; Tang G; Xu Q; Ji D; Boyer AD; Li F; Huang R; You MJ
    Am J Hematol; 2020 Feb; 95(2):E48-E51. PubMed ID: 31769058
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of novel recurrent CPSF6-RARG fusions in acute myeloid leukemia resembling acute promyelocytic leukemia.
    Liu T; Wen L; Yuan H; Wang Y; Yao L; Xu Y; Cen J; Ruan C; Wu D; Chen S
    Blood; 2018 Apr; 131(16):1870-1873. PubMed ID: 29487068
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of a novel CPSF6-RARG fusion transcript in acute myeloid leukemia resembling acute promyelocytic leukemia.
    Qin YZ; Huang XJ; Zhu HH
    Leukemia; 2018 Oct; 32(10):2285-2287. PubMed ID: 29568099
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome.
    Wu L; Li X; Su J; Chang C; He Q; Zhang X; Xu L; Song L; Pu Q
    Leuk Lymphoma; 2009 Sep; 50(9):1461-7. PubMed ID: 19672772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myeloid leukemia with CPSF6-RARG fusion resembling acute promyelocytic leukemia with extramedullary infiltration.
    Han X; Jin C; Zheng G; Li Y; Wang Y; Zhang E; Zhu H; Cai Z
    Ther Adv Hematol; 2021; 12():2040620720976984. PubMed ID: 33473264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukaemia with abnormal eosinophil precursors without inversion 16.
    Rashidi A; Roullet MR
    Br J Haematol; 2012 Sep; 158(5):561. PubMed ID: 22758220
    [No Abstract]   [Full Text] [Related]  

  • 7. Alkaloid-based regimen is beneficial for acute myeloid leukemia resembling acute promyelocytic leukemia with NUP98/RARG fusion and RUNX1 mutation: A case report.
    Wei W; Liu Q; Song F; Cao H; Liu M; Jiang Y; Li Y; Gao S
    Medicine (Baltimore); 2020 Oct; 99(40):e22488. PubMed ID: 33019444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21).
    Zhu HH; Jiang H; Jiang Q; Jia JS; Qin YZ; Huang XJ
    Leuk Res; 2016 May; 44():40-4. PubMed ID: 26994850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: A rare case of acute myeloid leukemia with CPSF6-RARG fusion resembling acute promyelocytic leukemia.
    Zhao J; Wang W; Yan L; Chen X; Li W; Li W; Chen T; Chen L
    Front Oncol; 2022; 12():1011023. PubMed ID: 36185228
    [No Abstract]   [Full Text] [Related]  

  • 10. Human leukocyte antigen-DR negative de novo acute myeloid leukemia with Philadelphia chromosome.
    Inaba T; Nishimura H; Saito J; Yamane Y; Nakatani T; Yamamoto M; Uchiyama H; Fujita N
    Int J Hematol; 2008 Dec; 88(5):602-605. PubMed ID: 19034612
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel
    Miller CA; Tricarico C; Skidmore ZL; Uy GL; Lee YS; Hassan A; O'Laughlin MD; Schmidt H; Tian L; Duncavage EJ; Griffith M; Griffith OL; Welch JS; Wartman LD
    Blood Adv; 2018 Jun; 2(11):1295-1299. PubMed ID: 29891591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very rare lineage switch from acute myeloid leukemia to mixed phenotype acute leukemia, B/Myeloid, during chemotherapy with no clonal evolution.
    Nomani L; Cook JR; Rogers HJ
    Int J Lab Hematol; 2019 Aug; 41(4):e86-e88. PubMed ID: 30707502
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-dose homoharringtonine and cytarabine in combination with granulocyte colony-stimulating factor for elderly patients with de novo acute myeloid leukemia.
    Chen C; Xu W; Yang J
    Leuk Lymphoma; 2015 Jan; 56(1):141-6. PubMed ID: 24724783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of decitabine, idarubicin, cytarabine, and G-CSF (DIAG) regimen for the treatment of high-risk myelodysplastic syndrome and acute myeloid leukemia.
    Zhang X; Guo X
    Ann Hematol; 2019 Sep; 98(9):2223-2225. PubMed ID: 30980106
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel entity of acute myeloid leukaemia with recurrent RARG-rearrangement resembling acute promyelocytic leukaemia.
    Luo H; Zhang S; Li K; Chen XH; Li YC; Sun Y; Liu LF; Yu HY; Zhu HH
    Leuk Res; 2019 Feb; 77():14-16. PubMed ID: 30612054
    [No Abstract]   [Full Text] [Related]  

  • 16. Using low-dose homoharringtonine and cytarabine in combination with granulocyte colony-stimulating factor in a priming induction therapy for acute myeloid leukemia: a retrospective study of 29 cases in china.
    Liu H; Zhang J; Ren S; Chen M; Liu L; Zhang H
    Leuk Lymphoma; 2017 Nov; 58(11):2758-2761. PubMed ID: 28406352
    [No Abstract]   [Full Text] [Related]  

  • 17. CHAG priming regimen containing of cytarabine, aclacinomycin homoharringtonine and G-CSF for relapsed refractory acute myelogenous leukemia: a modified combination chemotherapeutic combination.
    Chen L; Yin Q; Mi R; Wei X
    Leuk Lymphoma; 2013 Oct; 54(10):2291-3. PubMed ID: 23369043
    [No Abstract]   [Full Text] [Related]  

  • 18. Minimal residual disease may be an early prognostic indicator for newly diagnosed acute myeloid leukemia patients induced by decitabine-based chemotherapy.
    Tan Y; Fu Y; Liu C; Sun J; Liu S; Lin H; Liu Q; Yang Y; Li Y; Su L; Gao S
    Hematology; 2019 Dec; 24(1):552-558. PubMed ID: 31315553
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrent RARG trinary fusion and ligand binding domain truncation in variant acute promyelocytic leukemia resistant to retinoic acid but sensitive to homoharringtonine-based therapy.
    Chen X; Zhao Y; Zhou X; Chen J; Cao P; Wang F; Zhang Y; Wu P; Zhang L; Liu H
    Int J Lab Hematol; 2023 Dec; 45(6):1016-1019. PubMed ID: 37605819
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute myeloid leukemia with a severe coagulopathy and t(8;16)(p11;p13).
    Hastings A; Apperley JF; Nadal-Melsio E; Brown L; Bain BJ
    Am J Hematol; 2021 Jan; 96(1):163-164. PubMed ID: 32520413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.